Αρχειοθήκη ιστολογίου

Πέμπτη 15 Νοεμβρίου 2018

Long‐term clinical safety of Clindamycin and Rifampicin combination for the treatment of Hidradenitis Suppurativa: strategy to reduce side effects, improving patients’ compliance

Abstract

We read with great interest the article by Albrecht et al.1 regarding the long‐term clinical safety of Clindamycin and Rifampicin combination for the treatment of Hidradenitis Suppurativa (HS).

The authors discuss carefully whether Clindamycin and Rifampicin could be safely continued beyond a 10 week course, analyzing long term toxicity of these drugs.

This article is protected by copyright. All rights reserved.



https://ift.tt/2QJSOr0

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου